4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-13-015699
CIK 0000806888operating
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 8:04 PM ET
Size
18.2 KB
Accession
0001437749-13-015699
Insider Transaction Report
Form 4
PURVIN JEFFREY L
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2013-12-03$1.30/sh+3,695$4,804→ 8,795 total - Purchase
Common Stock
2013-12-04$1.27/sh+505$641→ 9,300 total - Purchase
Common Stock
2013-11-29$1.30/sh+800$1,040→ 5,100 total
Holdings
- 12,500(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]On June 19th, 2012, the final voting results of the annual meeting of the Company's shareholders effected a consolidation of the Company's outstanding common shares such that each twenty outstanding common shares will be consolidated into one common share.
- [F2]Shares held directly by the Purvin Family Trust, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 8:04 PM ET
- Size
- 18.2 KB